Pfizer Inc. (PFE) Tops Q1 EPS by 1c; Reaffirms Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $29.86 -0.83%
EPS Growth %: -16.1%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -16.1%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Pfizer Inc. (NYSE: PFE) reported Q1 EPS of $0.60, $0.01 better than the analyst estimate of $0.59. Revenue for the quarter came in at $16.5 billion versus the consensus estimate of $16.65 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Elevance Health Inc. (ELV) Tops Q3 EPS by $2.29, Beats on Revenue; Offers FY EPS Guidance
- Winnebago Industries (WGO) Misses Q4 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
